Gut bacteria molecule boosts lung cancer treatment response
A small compound produced naturally by gut bacteria doubled the response to lung cancer immunotherapy treatment in mice.
A small compound produced naturally by gut bacteria doubled the response to lung cancer immunotherapy treatment in mice.
Christian Jobin, Ph.D., wrote a column in the Tampa Bay Times on how Gatorade royalties have propelled innovation in his microbiome research.
Christian Jobin, Ph.D., shared his expertise with NPR on how gut bacteria damage may play a role in early-onset colorectal cancer.
Rachel Newsome will present her research on harnessing the gut microbiome to enhance the effectiveness of cancer immunotherapy treatment.
Learn about the latest research on colorectal cancer and get resources.
Christian Jobin, Ph.D., is the first distinguished professor in the UF Department of Medicine.
A toxin in the bacteria that’s one of the most common causes of foodborne illness accelerates the spread of colorectal tumors, a new study found.
The team will study the role of the gut microbiome in prostate cancer.